Saddled with sluggish sales, Regeneron and Sanofi slash the cost of cholesterol-lowering drug
Regeneron and Sanofi will soon offer a 60 percent discount off the $14,600 list price of cholesterol-lowering drug Praluent to clients of Express Scripts.
Frustrated by tepid sales and practical stumbling blocks, Regeneron and Sanofi are offering a huge discount on their treatment for bad cholesterol in exchange for a promise that health care’s biggest middleman will make it easier for patients to actually get the drug.
Starting in July, the two companies will sell their , which carries a $14,600 list price, at roughly 60 percent off. And, most important, Express Scripts will scrap the weeks of paperwork now required to approve a prescription, and implement a simple form that will allow doctors to get an immediate answer.
